Psychoneuroendocrinology
Volume 35, Issue 3 , Pages 422-429 , April 2010

Lower levels of prepulse inhibition in luteal phase cycling women in comparison with postmenopausal women

  • Elin Bannbers

      Affiliations

    • Department of Women's and Children's Health, Uppsala University, SE-751 85 Uppsala, Sweden
    • Corresponding Author InformationCorresponding author. Tel.: +46 18 611 57 87; fax: +46 18 55 97 75.
  • ,
  • Kristiina Kask

      Affiliations

    • Department of Women's and Children's Health, Uppsala University, SE-751 85 Uppsala, Sweden
  • ,
  • Johan Wikström

      Affiliations

    • Department of Oncology, Radiology and Clinical Immunology, Uppsala University, SE-751 85 Uppsala, Sweden
  • ,
  • Inger Sundström Poromaa

      Affiliations

    • Department of Women's and Children's Health, Uppsala University, SE-751 85 Uppsala, Sweden

Received 7 April 2009 ,Revised 10 August 2009 ,Accepted 11 August 2009.

References 

  1. Aasen I, Kolli L, Kumari V. Sex effects in prepulse inhibition and facilitation of the acoustic startle response: implications for pharmacological and treatment studies. J. Psychopharmacol. 2005;19:39–45
  2. Blumenthal TD. Prepulse inhibition decreases as startle reactivity habituates. Psychophysiology. 1997;34:446–450
  3. Blumenthal TD, Cuthbert BN, Filion DL, Hackley S, Lipp OV, van Boxtel A. Committee report: guidelines for human startle eyeblink electromyographic studies. Psychophysiology. 2005;42:1–15
  4. Borgstrom A, Kask K, Gulinello M, Odlind V, Sundström Poromaa I. Patients with adverse mood effects from combined oral contraceptives have lower levels of prepulse inhibition than healthy controls. Psychoneuroendocrinology. 2008;33:487–496
  5. Braff DL, Geyer MA, Swerdlow NR. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl.). 2001;156:234–258
  6. Cadenhead KS, Carasso BS, Swerdlow NR, Geyer MA, Braff DL. Prepulse inhibition and habituation of the startle response are stable neurobiological measures in a normal male population. Biol. Psychiatry. 1999;45:360–364
  7. Davis M. Neurochemical modulation of sensory-motor reactivity: acoustic and tactile startle reflexes. Neurosci. Biobehav. Rev. 1980;4:241–263
  8. Ellwanger J, Geyer MA, Braff DL. The relationship of age to prepulse inhibition and habituation of the acoustic startle response. Biol. Psychol. 2003;62:175–195
  9. Frey BN, Lord C, Soares CN. Depression during menopausal transition: a review of treatment strategies and pathophysiological correlates. Menopause Int. 2008;14:123–128
  10. Gogos A, Nathan PJ, Guille V, Croft RJ, van den Buuse M. Estrogen prevents 5-HT1A receptor-induced disruptions of prepulse inhibition in healthy women. Neuropsychopharmacology. 2006;31:885–889
  11. Gogos A, Van den Buuse M. Estrogen and progesterone prevent disruption of prepulse inhibition by the serotonin-1A receptor agonist 8-hydroxy-2-dipropylaminotetralin. J. Pharmacol. Exp. Ther. 2004;309:267–274
  12. Grillon C. Startle reactivity and anxiety disorders: aversive conditioning, context, and neurobiology. Biol. Psychiatry. 2002;52:958–975
  13. Hafner H, Maurer K, Loffler W, Riecher-Rossler A. The influence of age and sex on the onset and early course of schizophrenia. Br. J. Psychiatry. 1993;162:80–86
  14. Herrington DM, Vittinghoff E, Lin F, Fong J, Harris F, Hunninghake D, et al. Statin therapy, cardiovascular events, and total mortality in the Heart and Estrogen/Progestin Replacement Study (HERS). Circulation. 2002;105:2962–2967
  15. Hoenig K, Hochrein A, Quednow BB, Maier W, Wagner M. Impaired prepulse inhibition of acoustic startle in obsessive-compulsive disorder. Biol. Psychiatry. 2005;57:1153–1158
  16. Jovanovic T, Szilagyi S, Chakravorty S, Fiallos AM, Lewison BJ, Parwani A, et al. Menstrual cycle phase effects on prepulse inhibition of acoustic startle. Psychophysiology. 2004;41:401–406
  17. Kask K, Backstrom T, Gulinello M, Sundström Poromaa I. Lower levels of prepulse inhibition of startle response in pregnant women compared to postpartum women. Psychoneuroendocrinology. 2008;33:100–107
  18. Kask K, Backstrom T, Lundgren P, Sundström Poromaa I. Allopregnanolone has no effect on startle response and prepulse inhibition of startle response in patients with premenstrual dysphoric disorder or healthy controls. Pharmacol. Biochem. Behav. 2009;92:608–613
  19. Kask K, Gulinello M, Backstrom T, Geyer MA, Sundström Poromaa I. Patients with premenstrual dysphoric disorder have increased startle response across both cycle phases and lower levels of prepulse inhibition during the late luteal phase of the menstrual cycle. Neuropsychopharmacology. 2008;33:2283–2290
  20. Koch M. Sensorimotor gating changes across the estrous cycle in female rats. Physiol. Behav. 1998;64:625–628
  21. Kumari V, Aasen I, Papadopoulos A, Bojang F, Poon L, Halari R, et al. A comparison of prepulse inhibition in pre- and postmenopausal women and age-matched men. Neuropsychopharmacology. 2008;23:23
  22. Kumari V, Aasen I, Sharma T. Sex differences in prepulse inhibition deficits in chronic schizophrenia. Schizophr. Res. 2004;69:219–235
  23. Ludewig K, Ludewig S, Seitz A, Obrist M, Geyer MA, Vollenweider FX. The acoustic startle reflex and its modulation: effects of age and gender in humans. Biol. Psychol. 2003;63:311–323
  24. Ludewig S, Ludewig K, Geyer MA, Hell D, Vollenweider FX. Prepulse inhibition deficits in patients with panic disorder. Depress. Anxiety. 2002;15:55–60
  25. McEwen BS, Alves SE. Estrogen actions in the central nervous system. Endocr. Rev. 1999;20:279–307
  26. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br. J. Psychiatry. 1979;134:382–389
  27. Osterlund MK, Hurd YL. Estrogen receptors in the human forebrain and the relation to neuropsychiatric disorders. Prog. Neurobiol. 2001;64:251–267
  28. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results. From the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321–333
  29. Rupprecht R, Koch M, Montkowski A, Lancel M, Faulhaber J, Harting J, et al. Assessment of neuroleptic-like properties of progesterone. Psychopharmacology (Berl.). 1999;143:29–38
  30. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry. 1998;59(Suppl 20):22–33quiz 34–57
  31. Sundström I, Spigset O, Andersson A, Appelblad P, Backstrom T. Lack of influence of menstrual cycle and premenstrual syndrome diagnosis on pregnanolone pharmacokinetics. Eur. J. Clin. Pharmacol. 1999;55:125–130
  32. Swerdlow NR, Auerbach P, Monroe SM, Hartston H, Geyer MA, Braff DL. Men are more inhibited than women by weak prepulses. Biol. Psychiatry. 1993;34:253–260
  33. Swerdlow NR, Geyer MA, Braff DL. Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology (Berl.). 2001;156:194–215
  34. Swerdlow NR, Hartman PL, Auerbach PP. Changes in sensorimotor inhibition across the menstrual cycle: implications for neuropsychiatric disorders. Biol. Psychiatry. 1997;41:452–460
  35. Swerdlow NR, Light GA, Cadenhead KS, Sprock J, Hsieh MH, Braff DL. Startle gating deficits in a large cohort of patients with schizophrenia: relationship to medications, symptoms, neurocognition, and level of function. Arch. Gen. Psychiatry. 2006;63:1325–1335
  36. World Health Organization, WHO Scientific Group. Report of the WHO Scientific Group. Research on the Menopause in the 1990's: A. Geneva, 1996, pp. 866:861–879.

PII: S0306-4530(09)00247-9

doi: 10.1016/j.psyneuen.2009.08.004

Psychoneuroendocrinology
Volume 35, Issue 3 , Pages 422-429 , April 2010